✦ LIBER ✦

Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-{[4-(1H-tetrazol-5-ylmethyl)phenoxy]methyl}phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4and E4

✍ Scribed by Jerome H. Fleisch; Lynn E. Rinkema; Klaus D. Haisch; Doris McCullough; F. Patrick Carr; Robert D. Dillard

Book ID: 112375881
Publisher: Springer-Verlag
Year: 1986
Tongue: English
Weight: 847 KB
Volume: 333
Category: Article
ISSN: 0028-1298
DOI: 10.1007/bf00569663

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhanced activity of Ca2+-activated K+ c

Enhanced activity of Ca2+-activated K+ channels by 1-[2-hydroxy-3-propyl-4-[(1H-tetrazol-5-yl)butoxyl]phenyl] ethanone (LY-171883) in neuroendocrine and neuroblastoma cell lines

✍ Ping-Chia Li; Jin-Tung Liang; Hung-Tu Huang; Pei-Hsuan Lin; Sheng-Nan Wu 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

## Abstract The effects of LY‐171883, an orally active leukotriene antagonist, on membrane currents were examined in pituitary GH~3~ and in neuroblastoma IMR‐32 cells. In GH~3~ cells, LY‐171883 (1–300 μM) reversibly increased the amplitude of Ca^2+^‐activated K^+^ current in a concentration‐depende

Synthesis and pharmacological properties

Synthesis and pharmacological properties of N,N-dialkyl(dialkenyl)amides of 7-methyl-3-phenyl-1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-5-carboxylic acid

✍ Helena Śladowska; Aleksandra Sabiniarz; Barbara Filipek; Małgorzata Kardasz; Dor 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Investigations on the synthesis and phar

Investigations on the synthesis and pharmacological properties of amides of 7-methyl-3-phenyl-1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-2,4-dioxo-1,2,3,4-tetra-hydropyrido[2,3-d]pyrimidine-5-carboxylic acid

✍ Helena Śladowska; Maria Sieklucka-Dziuba; Grażyna Rajtar; Mirosław Sadowski; Zdz 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Synthesis and Pharmacological Properties

Synthesis and Pharmacological Properties of N,N-Dialkyl(dialkenyl)amides of 7-Methyl-3-phenyl-1- [2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl] -2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-5-carboxylic Acid.

✍ Helena Sladowska; Aleksandra Sabiniarz; Barbara Filipek; Malgorzata Kardasz; Dor 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 14 KB 👁 2 views

In vitro and in vivo pharmacological cha

In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V1A receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245)

✍ Rachel Russell; Rachel Doyle; Jamie Turner; Neil Attkins; Simeon Ramsey; Laura W 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 786 KB

Synthesis and pharmacological evaluation

Synthesis and pharmacological evaluation of 5-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-4,5,6,7-tetrahydro-thieno[3,2-c]pyridine derivatives as platelet aggregation inhibitors

✍ Challa, Nageswar Rao; Mamidisetty, Balaji; Ghanta, Mahesh Reddy; Padi, Pratap Re 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 501 KB